Avalo Therapeutics, Inc. SEC filings AVTX
Avalo Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, agreement ended). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| S-3 | Shelf registration | Jul 17, 2026 | — |
| 424B5 | Prospectus supplement | May 7, 2026 | — |
| 424B5 | Prospectus supplement | May 5, 2026 | — |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| S-3 | Shelf registration | Jan 8, 2026 | — |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| 424B5 | Prospectus supplement | Jun 5, 2025 | — |
| S-8 | Employee stock plan registration | May 12, 2025 | — |
| S-8 | Employee stock plan registration | May 12, 2025 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 424B3 | Prospectus | Aug 5, 2024 | — |
| S-3/A | Filing | Jul 29, 2024 | — |
| S-3/A | Filing | Jul 11, 2024 | — |
| S-3 | Shelf registration | Jun 6, 2024 | — |
| 424B5 | Prospectus supplement | Aug 7, 2023 | — |
| S-8 | Employee stock plan registration | May 4, 2023 | — |
| 424B5 | Prospectus supplement | May 4, 2023 | — |
| POS AM | Filing | Apr 25, 2023 | — |
| S-3 | Shelf registration | Apr 12, 2023 | — |
| 424B5 | Prospectus supplement | Feb 3, 2023 | — |
| 424B5 | Prospectus supplement | Feb 2, 2023 | — |
| S-8 | Employee stock plan registration | Nov 7, 2022 | — |
| 424B5 | Prospectus supplement | Sep 15, 2021 | — |
| 424B5 | Prospectus supplement | Sep 14, 2021 | — |
| 424B5 | Prospectus supplement | Jul 2, 2021 | — |
| S-8 | Employee stock plan registration | May 13, 2021 | — |
| S-8 | Employee stock plan registration | May 13, 2021 | — |
| S-8 | Employee stock plan registration | May 13, 2021 | — |
| S-3 | Shelf registration | Mar 8, 2021 | — |
| 424B5 | Prospectus supplement | Jan 8, 2021 | — |
| 424B5 | Prospectus supplement | Jan 7, 2021 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 424B5 | Prospectus supplement | Jun 9, 2020 | — |
| 424B5 | Prospectus supplement | Jun 8, 2020 | — |
| 424B3 | Prospectus | May 18, 2020 | — |
| S-3 | Shelf registration | May 12, 2020 | — |
| 424B5 | Prospectus supplement | Feb 4, 2020 | — |
| 424B3 | Prospectus | Dec 31, 2019 | — |
| S-4/A | Filing | Dec 30, 2019 | — |
| S-4 | Registration for a merger or exchange | Dec 20, 2019 | — |
| 424B3 | Prospectus | Oct 25, 2019 | — |
| S-3/A | Filing | Oct 18, 2019 | — |
| S-3 | Shelf registration | Sep 27, 2019 | — |
| 424B5 | Prospectus supplement | Mar 6, 2019 | — |
| FWP | Free writing prospectus | Mar 6, 2019 | — |
| FWP | Free writing prospectus | Mar 5, 2019 | — |
| 424B5 | Prospectus supplement | Mar 5, 2019 | — |
| 424B3 | Prospectus | Feb 11, 2019 | — |
| S-3 | Shelf registration | Jan 17, 2019 | — |
| 424B3 | Prospectus | Oct 5, 2018 | — |
| S-3/A | Filing | Oct 2, 2018 | — |
| 424B3 | Prospectus | Sep 26, 2018 | — |
| S-3 | Shelf registration | Sep 7, 2018 | — |
| S-8 | Employee stock plan registration | Aug 10, 2018 | — |
| 424B3 | Prospectus | Aug 9, 2018 | — |
| 424B3 | Prospectus | Jul 27, 2018 | — |
| 424B3 | Prospectus | Jul 16, 2018 | — |
| 424B3 | Prospectus | May 25, 2018 | — |
| 424B3 | Prospectus | May 21, 2018 | — |
| 424B3 | Prospectus | May 11, 2018 | — |
| 424B3 | Prospectus | Apr 2, 2018 | — |
| 424B3 | Prospectus | Apr 2, 2018 | — |
| 424B3 | Prospectus | Feb 23, 2018 | — |
| 424B3 | Prospectus | Feb 12, 2018 | — |
| 424B3 | Prospectus | Nov 17, 2017 | — |
| 424B3 | Prospectus | Nov 7, 2017 | — |
| 424B3 | Prospectus | Oct 20, 2017 | — |
| 424B3 | Prospectus | Oct 18, 2017 | — |
| 424B3 | Prospectus | Aug 25, 2017 | — |
| 424B3 | Prospectus | Aug 14, 2017 | — |
| 424B3 | Prospectus | Aug 14, 2017 | — |
| 424B3 | Prospectus | Jul 7, 2017 | — |
| 424B3 | Prospectus | Jul 7, 2017 | — |
| S-3 | Shelf registration | May 26, 2017 | — |
| 424B3 | Prospectus | May 9, 2017 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534120
- Former names
- Cerecor Inc. (until Aug 18, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.